Orchard Therapeutics Stock Forecast
News orchard therapeutics plc adrortx. This is 0.79% more than the trading day before wednesday, 1st dec 2021.
30 rows about the orchard therapeutics plc stock forecast.
Orchard therapeutics stock forecast. No news for in the past two years. Wall street stock market & finance report, prediction for the future: According to 10 analysts, the average rating for ortx stock is strong.
This is 10.73% less than the trading day before monday, 15th nov 2021. On average, wall street analysts predict that. Their forecasts range from $12.00 to $14.00.
Find the latest orchard therapeutics plc (ortx) stock quote, history, news and other vital information to help you with your stock trading and investing. Orchard therapeutics plc adr is in the bottom half of stocks based on the fundamental outlook for the stock and an analysis of the stock's chart. The company listed on the u.s.
On average, they anticipate orchard therapeutics' share price to reach $12.75 in the next twelve months. Orchard therapeutics's share price could stay at $14.00 by nov 16, 2022. The average orchard therapeutics stock price prediction forecasts a potential downside of n/a from the current ortx share price of $1.21.
The highest, average, and lowest price target of all. Close price at the end of the last trading day (thursday, 2nd dec 2021) of the ortx stock was $1.28. There are currently 4 buy ratings for.
There are few to no technical positive signals at the moment. According to the issued ratings of 4 analysts in the last year, the consensus rating for orchard therapeutics stock is buy based on the current 1 sell rating and 3 buy ratings for ortx. Stock was originally listed at a price of $14.00 in oct 31, 2018.
This suggests a possible upside of 953.7% from the stock's current price. This chart shows the closing price for ortx. Orchard stock forecast is based on your current time horizon.
Get the latest orchard therapeutics stock price and detailed information including ortx news, historical charts and realtime prices. The price to earnings (p/e) ratio, a key valuation measure, is calculated by. The average price target represents a 382.97% change from the last price of $2.76.
During the day the stock fluctuated 11.58% from a day low at $1.51 to a day high of $1.69. During the day the stock fluctuated 7.50% from a day low at $1.20 to a day high of $1.29. Close price at the end of the last trading day (tuesday, 16th nov 2021) of the ortx stock was $1.58.
The average price target represents a 896.09% upside from the last price of $1.28. 4 wall street analysts have issued ratings and price targets for orchard therapeutics in the last 12 months. Further, orchard therapeutics plc (ortx) has a beta value of 0, and an average true range (atr) of 0.11.
The high price target for ortx is $16.00 and the low price target for ortx is $12.00. The average price target is $12.75, with a high forecast of $14.00 and a low forecast of $12.00. Based on 5 wall street analysts offering 12 month price targets for orchard therapeutics in the last 3 months.
However, solely looking at the historical price movement is usually misleading. Stock markets in 2018 and. The average price target is $13.33 with a high forecast of $15.00 and a low forecast of $12.00.
A rank of 39 means that 61% of stocks appear more favorable to our system. As of 2021 november 25,. This price target is based on 4 analysts offering 12 month price targets for orchard therapeutics in the last 3 months.
Investorsobserver gives orchard therapeutics plc adr (ortx) an overall rank of 39, which is below average.
Post a Comment for "Orchard Therapeutics Stock Forecast"